Literature DB >> 16965202

Association of PTSD and depression with medical and specialist care utilization in modern peacekeeping veterans in Canada with health-related disabilities.

J Don Richardson1, Jon D Elhai, David J Pedlar.   

Abstract

OBJECTIVE: We examined the relative associations between posttraumatic stress disorder (PTSD) and depression severity with medical and specialist care use in modern peacekeeping veterans with health-related disabilities.
METHOD: The participants consisted of 1016 male veterans who served in the Canadian Forces from 1990 to 1999, selected from a larger random sample of 1968 veterans who voluntarily completed an anonymous general health survey conducted by Veterans Affairs Canada in 1999. Survey instruments included the PTSD Checklist-Military Version (PCL-M), Center for Epidemiological Studies-Depression Scale, and questionnaires of health problems and service use, sociodemographic characteristics, and military history.
RESULTS: Among peacekeeping veterans with health disabilities, "probable" PTSD (PCL-M score > or = 50) was associated with significantly more medical service use (primary and specialty care combined), with a mean of 16.4 times (SD = 17.4) compared with 6.0 times (SD = 6.6), p < .001, for veterans without PTSD. We found that in multivariate analyses, general medical care intensity (i.e., number of visits) was related to increased health problems, greater probable PTSD diagnosis, and greater depression symptom severity. We also found that depression severity accounted for health care use intensity and that PTSD only added a small amount of incremental variance above that.
CONCLUSIONS: The observed association between PTSD (diagnosis and severity) and medical care utilization stresses the importance of PTSD screening in primary care settings, especially in patients with a history of military service. This association is also useful for clinicians and hospital administrators in understanding potential medical and psychiatric needs for military veterans.

Entities:  

Mesh:

Year:  2006        PMID: 16965202     DOI: 10.4088/jcp.v67n0810

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  6 in total

1.  Horror comes home: veterans with posttraumatic stress disorder.

Authors:  J Don Richardson; James M Thompson; Margaret Boswall; Rakesh Jetly
Journal:  Can Fam Physician       Date:  2010-05       Impact factor: 3.275

2.  Mental Health Services Use Trends in Canadian Veterans: A Population-Based Retrospective Cohort Study in Ontario.

Authors:  Alyson L Mahar; Alice B Aiken; Heidi Cramm; Marlo Whitehead; Patti Groome; Paul Kurdyak
Journal:  Can J Psychiatry       Date:  2017-09-14       Impact factor: 4.356

3.  Trauma Exposure and Posttraumatic Stress Disorder in the Canadian Military.

Authors:  Alain Brunet; Eva Monson; Aihua Liu; Deniz Fikretoglu
Journal:  Can J Psychiatry       Date:  2015-11       Impact factor: 4.356

4.  Aripiprazole augmentation in the treatment of military-related PTSD with major depression: a retrospective chart review.

Authors:  J Don Richardson; Deniz Fikretoglu; Aihua Liu; Diane McIntosh
Journal:  BMC Psychiatry       Date:  2011-05-17       Impact factor: 3.630

5.  Well-being of Canadian Armed Forces Veterans and Spouses of Veterans During the COVID-19 Pandemic: Protocol for a Prospective Longitudinal Survey.

Authors:  Callista A Forchuk; Anthony Nazarov; Rachel A Plouffe; Jenny J W Liu; Erisa Deda; Tri Le; Dominic Gargala; Vanessa Soares; Jesse Bourret-Gheysen; Kate St Cyr; Maede S Nouri; Fardous Hosseiny; Patrick Smith; Gabrielle Dupuis; Maya Roth; Michelle Marlborough; Rakesh Jetly; Alexandra Heber; Ruth Lanius; J Don Richardson
Journal:  JMIR Res Protoc       Date:  2022-01-11

6.  Mental health diagnoses and utilization of VA non-mental health medical services among returning Iraq and Afghanistan veterans.

Authors:  Beth E Cohen; Kris Gima; Daniel Bertenthal; Sue Kim; Charles R Marmar; Karen H Seal
Journal:  J Gen Intern Med       Date:  2009-09-29       Impact factor: 5.128

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.